Camden Capital, LLC Edwards Lifesciences Corp Transaction History

Camden Capital, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $15,549 - $18,017	-191 Reduced 5.56%	3,243 $305,000
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $255,008 - $290,207	3,434 New	3,434 $284,000
Q3 2022 Nov 08, 2022	SELL	$82.37 - $107.29 $13,755 - $17,917	-167 Reduced 5.39%	2,933 $242,000
Q2 2022 Aug 03, 2022	BUY	$86.5 - $128.27 $10,293 - $15,264	119 Added 3.99%	3,100 $295,000
Q1 2022 May 06, 2022	BUY	$101.96 - $128.34 $42,823 - $53,902	420 Added 16.4%	2,981 $351,000

Q4 2021 Feb 28, 2022	SELL	$106.37 - $130.68 $12,764 - $15,681	-120 Reduced 4.48%	2,561 $332,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $10,211 - $12,545	-96 Reduced 3.46%	2,681 $347,000
Q3 2021 Nov 03, 2021	SELL	$102.91 - $122.75 $59,070 - $70,458	-574 Reduced 17.13%	2,777 $314,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $32,865 - $41,065	392 Added 13.25%	3,351 $347,000
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $36,900 - $42,524	469 Added 18.84%	2,959 $247,000
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $178,508 - $227,162	2,490 New	2,490 $227,000
Q1 2020 Apr 13, 2020	SELL	$52.41 - $81.0 $14,936 - $23,085	-285 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $20,434 - $23,395	285 New	285 $66,000

1,377

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Camden Capital, LLC with notifications on news.